EA
MDT icon

Emerald Advisors’s Medtronic MDT Stock Holding History

Emerald Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,335
Closed -$202K – 139
2026
Q1 		$202K Buy
+2,335
New +$224K 0.03% 119
2021
Q4 		– Sell
-4,401
Closed -$552K – 105
2021
Q3 		$552K Buy
4,401
+134
+3% +$17.3K 0.16% 50
2021
Q2 		$530K Buy
4,267
+199
+5% +$25K 0.17% 52
2021
Q1 		$481K Sell
4,068
-274
-6% -$32.1K 0.17% 43
2020
Q4 		$509K Buy
+4,342
New +$478K 0.18% 40
2020
Q1 		– Sell
-2,856
Closed -$341K – 96
2019
Q4 		$341K Buy
+2,856
New +$313K 0.32% 57

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Emerald Advisors's MDT Position: Q2 2026 in Review

Emerald Advisors sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,335 shares — an estimated $202K sold.

Emerald Advisors first reported a position in MDT in Q4 2019 and held it in 6 quarters. The position peaked at $552K in Q3 2021. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Emerald Advisors reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Emerald Advisors sold 2,335 Medtronic shares in Q2 2026, an estimated $202K.
  • Emerald Advisors first reported a position in Medtronic in Q4 2019 and held it in 6 quarters.
  • Emerald Advisors's Medtronic position peaked at $552K in Q3 2021.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Emerald Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.